|Bid||33.80 x 2700|
|Ask||33.81 x 600|
|Day's Range||33.67 - 34.07|
|52 Week Range||25.55 - 35.60|
|PE Ratio (TTM)||22.19|
|Dividend & Yield||0.90 (2.75%)|
|1y Target Est||N/A|
AstraZeneca (AZN) needs Investors to pay close attention to the stock based on moves in the options market lately.
On the hunt for a fat dividend yield? These three big pharma stocks deliver.
There were multiple presentations at European Society for Medical Oncology 2017 Congress. AstraZeneca's lung cancer study data was positive and so was Bristol-Myers's melanoma candidate.